ABSTRACT
The contributions of this work can be summarized by three main points:
First, the development of a neuroprosthesis technology platform that can be
readily adapted to new in vivo applications. Second, an analysis method that
can quantitatively determine the extent of the post-implantation tissue reaction.
Lastly, the development and evaluation of a novel drug-eluting coating that
